Webinar • Video

The consensus is clear: metabolomic data can play a pivotal role in understanding key questions across the life sciences. For example, in population health, metabolomics is increasingly viewed as a robust phenotyping tool with the power to link genomic and transcriptomic variation on the one hand with clinical outcomes on the other hand. Likewise, in drug development, metabolomics offers a vast trove of potential biomarkers for monitoring disease progression, drug efficacy, and both on- and off-target toxicity.

Metabolon has always sought to deliver innovative solutions and support each client’s key research objectives by addressing common pain points and overcoming previous pitfalls of metabolomic analysis. Recently, our efforts to broaden metabolomics access and utility reached a new level through the expansion of our support to include dried blood spot (DBS) card samples.

This validated solution provides researchers with an alternative solution when access to, or appropriate storage and handling of, blood plasma and/or serum is limited or not possible.

Metabolon experts provide an overview of Metabolon’s Precision MetabolomicsTM platform and a deeper dive into the extensive validation work that was conducted in dried blood spot (DBS) samples.

Watch this on-demand event to:
• Explore the benefits of adding metabolomics to your research
• Hear about the biological and analytical findings from the DBS sample validation
• Discover the benefits of DBS samples